ISOSORBIDE MONONITRATE
NDC 59651-541, ISOSORBIDE MONONITRATE, tablet, extended release, from Aurobindo Pharma Limited.
- Product NDC
- 59651-541
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216557
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-541 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ISOSORBIDE MONONITRATE120 mg/1
Pharmacologic classes
Nitrate Vasodilator [EPC]; Nitrates [CS]; Vasodilation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-541-01 | 59651054101 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-541-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/55810c9d-1140-40b8-a297-210a84afc05aNADAC price for package 59651054101
GET /v1/drugs/nadac/59651054101
Use it
Look up 59651-541 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-541 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-541. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.